Session Details
[1MS-08]【J】Proteostasis as a Key to Neurological disorders: A New Perspective on Ubiquitination and Protein Degradation
Wed. Dec 3, 2025 11:15 AM - 12:35 PM JST
Wed. Dec 3, 2025 2:15 AM - 3:35 AM UTC
Wed. Dec 3, 2025 2:15 AM - 3:35 AM UTC
Room 8(Pacifico Yokohama Conference Center 3F, 315)
Organizer: Gen Matsumoto (Osaka Metropolitan University ), Shuji Wakatsuki (National Center of Neurology and Psychiatry )
Abnormalities in neuronal proteostasis, which involve disruptions in protein synthesis, folding, and degradation, are key contributors to neurodegenerative and psychiatric disorders. Proteostasis is maintained by intracellular factors, with the ubiquitin chain addition and protein degradation systems playing a critical role. These systems eliminate abnormal proteins and regulate signal transduction. Dysfunction in these processes leads to protein accumulation and cell degeneration, contributing to disease development. This symposium will explore the molecular mechanisms of proteostasis abnormalities, their impact on disease onset, and potential treatment strategies.
Introduction
[1MS-08-01]E3 ubiquitin ligase ZNRF1 regulates AIS structure and fear behavior
○Shuji Wakatsuki1, Moeka Ohno1,2, Toshiyuki Araki1,2 (1. NCNP, 2. Tokyo Univ. Agri Tech)
[1MS-08-02]Progressive complex ubiquitination in neurodegenerative diseases and linear ubiquitin modification as a drug target
○Daisuke Oikawa1, Yukari Hatanaka1, Fuminori Tokunaga1,2 (1. Dept. of Med. Biochem., Grad. Sch. of Med., Osaka Metropol. Univ., 2. Res. Inst. for Drug Discov. Sci., Osaka Metropol. Univ.)
[1MS-08-03]Development of an Optogenetic Tau Aggregation Tool for Functional Analysis of Tau Aggregates and Single Particle Tracking-Based Evaluation of Monomeric Tau Effects
○Shigeo Sakuragi1 (1. Waseda university)
[1MS-08-04]Modulation of Selective Autophagy for Suppression of Tau Aggregation and Disease Modification Strategies
○Gen Matsumoto1 (1. Osaka Metropolitan Univ.)
